Cargando…
Midkine is a serum and urinary biomarker for the detection and prognosis of non-small cell lung cancer
Midkine, a heparin-binding growth factor, has been identified as a promising cancer biomarker. In non-small cell lung cancer (NSCLC), the serum and urine midkine levels have not been intensively investigated. The aim of the present study was to investigate the diagnostic and prognostic potential of...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5350001/ https://www.ncbi.nlm.nih.gov/pubmed/27974680 http://dx.doi.org/10.18632/oncotarget.13865 |